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ABSTRACT 
Poor mental health remains a serious public concern worldwide. The most vulnerable 
individuals are children and adolescents in developing countries. Nutritional deficiency of 
Omega-3 DHA and EPA has long been recognized as a major contributing factor for mental 
health illnesses. Provision of ready-to-use natural product rich in preformed Omega-3 DHA 
could address this problem. However, most commonly used products are expensive and 
contain less or no preformed Omega-3 DHA, making them less suitable for prevention of 
mental illnesses in resource-poor countries. The main objective of this study was to develop a 
natural product rich in preformed Omega-3 DHA and EPA from locally available 
ingredients. Linear programming (LP) was used to formulate a natural product rich in 
preformed Omega-3 DHA and other essential nutrients using locally available ingredients 
other than fish and dairy products. Laboratory analysis was then performed to validate the 
nutritional value of the LP-formulation using standard analytical methods. The relative 
difference between the LP tool calculated values and the laboratory-analysed values were 
calculated. Sensory testing was also done to evaluate consumer acceptance of the final 
product. Optimal formulation contained 220 mg of preformed Omega-3 DHA+EPA, enough 
to meet the RDI for children aged 2-10 years. The LP analysis further showed that the cost of 
present product is USD 0.15/100 g, which is 50% lower than that of Plumpy’nut. Laboratory 
analysis revealed similar results as that of LP at P=0.05. These findings indicate that ready-
to-use natural food rich in preformed DHA and EPA can be developed from locally available 
ingredients. 
Keywords: microalgae, mental health, preformed Omega-3 DHA, nutrition, nutrient-based 
intervention, linear programming. 
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1.1 Background of the problem  
Mental health problems represent a significant public health concern worldwide (World Bank 
Group/ WHO, 2016). The problem accounts for 13% of the overall global burden of disease. 
It also accounts for more than one third of adult disabilities (Vigo et al., 2016). The most at 
risk individuals are young children, adolescents and women of the reproductive age. Briefly, 
mental illness is a diagnosable mental health disorder, which is characterized by alterations in 
thinking, mood, or behaviors associated with distress and or impaired functioning. The 
problem is more prevalent in developing countries, especially in households that are in 
resource-poor environments (World Bank Group/ WHO, 2016). In Tanzania for instance, the 
regional analysis has shown that the average dietary intake of DHA is 57.1 mg/day, which 
groups the country among countries with the lowest DHA dietary intake in the world (Forsyth 
et al., 2016). Nutritional deficiency has long been recognized as a major contributing factor 
of mental disorders in resource-poor countries (Korn, 2016). The most common nutritional 
deficiencies seen in patients with mental disorders are Omega-3 fatty acids, B vitamins, 
minerals and amino acids, all of which are precursors to neurotransmitters (Rao et al., 2008). 
Since nutrition is clearly linked with mental health, the field of nutrition has recently received 
attention as a sustainable approach to both the prevention and management of mental health 
disorders in low and high income countries (Marx et al., 2017; Ramakrishnan et al., 2009). 
Convincing data suggest that nutrient-based supplements might provide many neurochemical 
modulatory activities that are beneficial in the prevention and management of mental health 
disorders (Forsyth et al., 2017). Because of that, there are a number of nutrient-based 
interventions that are currently being implemented especially, in developed countries (Panse 
& Phalke, 2016). Long-chain Omega-3 fatty acids supplementation, especially 
docosahexaenoic acid (DHA) is an example of the available nutrient-based interventions for 
prevention and or management of mental disorders (Stark et al., 2016). The assertion is based 
on the clinical trials that have proved the usefulness of omega-3 DHA in prevention and 
management of psychosis, bipolar depression, major depression and post-traumatic stress 
disorder (Sun et al., 2018; Thome Research Inc., 2009). 
Omega-3 fatty acids, especially docosahexaenoic acid (DHA) have a wide range of 
scientifically established health benefits attributed to their consumption. Docosahexaenoic 
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acid is highly concentrated in the brain, and is absolutely essential for proper brain 
development and cognitive function of infants and young children (Markhus et al., 2015). 
Docosahexaenoic acid is crucial at all stages of life but particularly in pre conception, 
pregnancy and childhood years. Brain development continues through childhood and early 
adolescence, with cerebral volume reaching 95% of its peak by six years of age and reaching 
its maximum between 10 and 15 years of age (Weiser et al., 2016). Studies have reported that 
poor DHA status may affect brain development as well as the cognitive abilities of children 
(Forsyth et al., 2016).  
Functional foods that are rich in alpha-linolenic acid (ALA) are being promoted as the 
reliable alternative source of DHA. The assertion is based on a scientific fact that dietary 
ALA can be converted into DHA within the body (Dewick, 2009). Furthermore, the 
ingredients that are rich in ALA are readily available in the global market. Some of the well-
studied ALA-rich ingredients available in the market include soybeans, chia seeds, flaxseed, 
walnut and canola (Lenihan-Geels et al., 2013). Because of the reported health benefits of 
omega-3 fatty acids, there are a number of omega-3 products on the global market that are 
being advertised as foods for brain development and cognitive function (Panse & Phalke, 
2016). One should however, note that omega-3 DHA cannot be synthesized de novo in 
humans, and therefore, must be obtained directly from the diet or synthesized within the body 
from ALA (Sun et al., 2018). However, conversion of ALA into DHA is almost negligible. 
Therefore, consuming ingredients that are rich in omega-3 ALA may not confer any 
physiological benefit to the brain. Therefore, consuming ingredients that are rich in omega-3 
ALA may not confer any physiological benefit to the brain.  
Currently, fish oils represent the most prominent dietary sources of omega-3 DHA. However, 
according to Lane and colleagues, there are several limitations to relying fish oils as a source 
of supply of omega-3 DHA (Lane et al., 2014). Some of these limitations include the 
undesirable odors, flavors, and tastes of fish oils, which discourage consumers from 
consuming them in their pure forms, and neither is traditional supplementation much 
appreciated. Furthermore, some fish contain high levels of methyl-mercury, which creates a 
risk of mercury poisoning to consumers. Furthermore, some fish are likely to contain high 
levels of methyl-mercury, creating a risk of mercury poisoning. In addition, environmental 
contaminants such as dioxins and polychlorinated biphenyls have been found in fish oils, 
which may dissuade its use. In addition, fish oil has already reached maximum global 
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production and its stock is decreasing throughout the world, thus may not be a sustainable 
source of DHA, especially in resource-poor countries. This calls for development of products 
or formulations that are rich in preformed DHA and other health promoting compounds from 
other sources. 
Consumption of products that are rich in preformed DHA and cofactors could ensure 
bioavailability of dietary omega-3 DHA in the body. Tanzania is among the global baskets of 
ingredients (e.g. microalgae) that are naturally packed with preformed omega-3 DHA and 
other health promoting compounds that are mostly absent in typical African diets for children 
and the general population (Rajauria et al., 2015). Unlike other countries, these natural 
ingredients are not yet fully utilized for human consumption in Tanzania, neither have the 
guidelines for omega-3 DHA intake been developed. This underscores the need for 
formulating a natural product from locally available ingredients that are rich in preformed 
omega-3 DHA and other essential nutrients and make them available for human consumption 
in the country. 
So far, there is no convenient optimal formulation rich in preformed DHA and EPA for 
human consumption in Tanzania and East Africa at large despite the presence of microalgae, 
which is a cheap and sustainable natural source of omega-3 DHA and other health promoting 
compounds. Majority of omega-3 products that are found in the market are ALA, whose 
conversion in the body may not achieve the recommended daily intake of DHA. Since food 
companies know that only few consumers understand the difference between ALA and DHA 
omega-3, they sucker people into buying ALA products by advertising them as omega-3. 
Under this circumstance, the status of DHA among the consumers is likely to be very poor, 
especially among vulnerable individuals in developing countries (Forsyth et al., 2016). Poor 
DHA status may affect brain development as well as the cognitive abilities of infants and 
young children. Thus, bioavailable omega-3 DHA should be included in the diets for infants 
and children to ensure optimal brain and cognitive development (Sun et al., 2018). 
Maintaining individual’s mental health is important to improve personal life values, to reduce 
medical costs and other social expenses that are incurred in dealing with mental disorders, 
and to enhance national competitiveness (World Bank Group/ WHO, 2016).  
Optimal use of locally available ingredients other than fish oil can ensure dietary adequacy of 
bioavailable omega-3 DHA and other health promoting compounds among the vulnerable 
individuals in developing countries like Tanzania. This can be achieved using linear 
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programming (LP) techniques. Linear programming is a mathematical tool which allows 
generation of optimal solutions that satisfy nutritional and other constraints at once (Dibari et 
al., 2012). It has been used in optimizing the ratio of omega-3 and omega-6 fatty acids for 
health promoting diets (Cahyaningrum et al., 2016). Linear programming can therefore, be 
used in formulation of ready to use natural products that are rich in preformed DHA and other 
health promoting compounds. The technique can also be used to inform regulatory authorities 
to design appropriate policies and dietary guidelines for omega-3 DHA that are currently 
missing in developing countries. The aim of this study was to formulate a ready to use natural 
product rich in preformed omega-3 DHA and other essential nutrients from locally available 
ingredients other than fish oil and dairy sources using linear programming. Optimized 
formulation can be used to prevent mental disorders associated with poor nutrition among 
individuals in Tanzania and other countries facing similar challenge. 
1.2 Statement of the problem 
The research problem being addressed in this study is the development of a convenient 
natural product rich in bioavailable omega-3 DHA and EPA fatty acids. So far, there is no 
convenient natural product, which is rich in bioavailable DHA in Tanzania and other similar 
places in sub-Saharan Africa. Majority of omega-3 products that are found in the market are 
ALA, whose conversion in the body may not achieve the recommended daily intake of DHA. 
Since only few consumers understand the difference between ALA and DHA omega 3, 
companies use this advantage to sell ALA products by advertising them as omega 3. Under 
this circumstance, the status of DHA among the consumers is likely to be very poor, 
especially among vulnerable individuals in developing countries (Forsyth et al., 2016).  Poor 
DHA status may affect brain development as well as the cognitive abilities of infants and 
young children. Thus, bioavailable omega-3 DHA should be included in the diets of infants 
and children to ensure optimal brain development and cognitive performamnce (Sun et al., 
2018).  
1.3 Rationale of the study  
Omega-3 DHA is vital at all stages of life but, particularly, in pre-conception, pregnancy and 
childhood years. Low DHA content can lead to poorer brain development and cognitive 
performance of a growing child. Thus, it is vital that pregnant and lactating women as well as 
infants consume sufficient preformed DHA to support mental health. Maintaining 
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individual’s mental health is important to improve personal life values, to reduce medical 
costs and other social expenses that are incurred in dealing with mental disorders, and to 
enhance national competitiveness (World Bank Group/ WHO, 2016). 
1.4 Objectives  
1.4.1 General objective 
The main objective of this study was to develop a convenient natural product rich in 
preformed omega-3 DHA and EPA fatty acids, and cofactors for conversion of ALA into 
DHA. 
1.4.2 Specific objectives  
(i) To identify suitable local ingredients for developing omega-3 DHA natural product  
(ii) To design optimal formulation for developing a natural product rich in preformed 
omega-3 DHA and its absorption cofactors 
(iii) To develop natural product prototype rich in bioavailable omega-3 DHA and 
cofactors 
(iv) To evaluate consumer acceptance and willingness to pay for the final product 
1.5 Hypothesis 
Local ingredients other than fish oil (if optimized) can ensure dietary adequacy of 
bioavailable omega-3 DHA and EPA among the vulnerable individuals in developing 
countries 
1.6 Significance of the study 
The natural product from this research study will improve mental health of consumers, 
especially children and enable them to realize their own potential, cope with the normal 
stresses of life, work productively and fruitfully, and make a significant contribution to their 
community at large. Similarly, this natural product will contribute significantly to the current 
global efforts of preventing maternal and child mental health illness. In a long-term plan, this 
product will be commercialized, which in turn will create direct employment and increase the 
value of indirect jobs in Tanzanian and East Africa in general.  
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1.7 Delineation of the study  
This study was conducted to develop a natural product rich in preformed omega-3 DHA and 
other essential nutrients from locally available ingredients in Tanzania. Linear programming 
techniques was used to develop this natural product rich in preformed omega-3 DHA and 
other essential nutrients from identified local ingredients. Laboratory analysis and sensory 
evaluation were performed to validate nutritional and sensory qualities of the product. 
Findings from the present study show that acceptable and convenient ready-to-use natural 
product rich in preformed DHA and other essential nutrients can be developed from locally 





2.1 Global state of mental health disorders 
Poor mental health remains a public concern worldwide. The global burden of mental health 
problems is high, and is predicted to rise in the near future. The most at risk individuals are 
children, adolescents and women of reproductive age in developing countries. The 2016 
World Bank Group and World Health Organization estimates (World Bank Group/ WHO, 
2016) indicate that more than 10% of the world’s population is affected by mental disorders 
and that 20% of children and adolescents suffer from some type of mental disorder. In fact, 
mental disorders account for 30% of non-fatal disease burden worldwide and 10% of overall 
disease burden, including death and disability. Low- and middle-income countries contribute 
about 80% of individuals who are likely to experience an incidence of a mental disorder in 
their lifetime. Generally, mental illness include depression, bipolar disorder, schizophrenia, 
eating disorders and anxiety disorders, attention deficit disorder, autism and addiction. But, 
the most common childhood mental disorders are anxiety disorders, depression, autism and 
attention deficit hyperactivity disorder (ADHD) (Rao et al., 2008). The devastating situation 
of mental health problem in developing countries underscores the need for setting sustainable 
approach to address the issue.  If the problem is left unattended, may lead to adverse socio 
and economic consequences at both individual and community levels.  
2.2 Socio-economic consequences of mental health disorders 
Mental disorders impose an enormous burden on society accounting for almost one in three 
years lived with disability globally (World Bank Group/ WHO, 2016). Additionally, mental 
disorders cause a significant economic burden due to lost economic output and the link 
between mental disorders and costly, potentially fatal conditions including cancer, 
cardiovascular disease, diabetes and obesity (Vigo et al., 2016). The recent World Bank 
estimates show that the lost economic output caused by untreated mental disorders as a result 
of diminished productivity at work, reduced rates of labor participation, foregone tax receipts 
and increased welfare payments amounts to about US$1 trillion per year (World Bank Group/ 
WHO, 2016). More than 54% of the estimated global cost of mental disorders was borne by 
developing countries and by 2030 that cost is projected to reach 58%. These socio-economic 
impacts of mental health disorders underscore the need to reduce the prevailing burden of 
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mental health disorders at the household level and national level. The only sustainable 
method for reducing the burden caused by mental health disorders is prevention (WHO, 
2014). 
2.3 Poor nutrition as a major cause of mental health disorders 
Poor nutrition has long been recognized as one the contributing factors of mental illnesses 
among individuals in developing countries (Korn, 2016). The most common nutritional 
deficiencies seen in patients with mental illnesses are omega-3 DHA and EPA fatty acids, B 
vitamins, minerals and amino acids, all of which are precursors to neurotransmitters (Rao et 
al., 2008). This implies that provision of products that are rich in omega-3 fatty acids, 
particularly the one with high biological value could address the problem of mental disorders 
in the affected population. Evidence from previous studies show that nutrient-based 
supplements might provide many neurochemical modulatory activities that are beneficial in 
the prevention and management of mental health disorders (Forsyth et al., 2017). However, 
the most commonly used omega-3 products; especially in developing countries do not contain 
bioavailable omega-3 DHA. This underscore the need for looking a safe source of 
bioavailable omega-3 DHA and other essential nutrients that are direct linked to prevention 
of mental health illnesses. 
2.4 Omega-3 based interventions for addressing mental health disorders 
The field of nutrition has recently received attention as a sustainable  solution the prevailing  
mental health disorders in both low and high income countries (Marx et al., 2017; 
Ramakrishnan et al., 2009). The assertion is based on clinical trials which have shown that 
nutrient-based supplements can provide many neurochemical modulatory activities that are 
beneficial in the prevention and management of mental health disorders (Forsyth et al., 
2017).  Success stories of these clinical trials have prompted scientists from to develop are a 
number of nutrient-based interventions to promote mental health in the world (Panse & 
Phalke, 2016). Supplementation of omega-3 fatty acids, especially, docosahexaenoic acid 
(DHA) is an example of available nutrient-based interventions that have shown promising 
results in improving mental health. A number of studies have demonstrated usefulness 
omega-3 DHA in preventing and or treating mental health disorders (Sun et al., 2018; Thome 
Research Inc., 2009).  Some of the reported mental disorders that have been treated using 
omega-3 DHA include but not limited to bipolar depression, major depressive disorder, post-
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traumatic stress disorder, schizophrenia, psychosis and attention deficit hyperactivity disorder 
(ADHD). 
Omega-3 DHA can provide a range of neurochemical activities via the following 
mechanisms: modulation of neurotransmitter (noradrenaline, dopamine and serotonin) re-
uptake, degradation, synthesis and receptor binding; anti-inflammatory and antiapoptotic 
effects; and the enhancement of cell membrane fluidity and neurogenesis via upregulation of 
brain-derived neurotrophic factor (BDNF) (Sun et al., 2018). Some other nutrients that boost 
the activity of omega-3 DHA in the central nervous system include S-adenosyl methionine 
(SAMe), N-acetyl cysteine (NAC), zinc, B vitamins (including folic acid), magnesium, 
vitamin C and vitamin D (Sun et al., 2018; Thome Research Inc., 2009). This means that 
nutrient-based interventions that consider using sources or products that are rich in both the 
omega-3 DHA and its cofactors are likely to have a more significant impact on mental health 
improvement.  
2.5 Prevailing sources of omega-3 DHA and their drawbacks 
The DHA found in the brain is not produced de novo in mammals. Instead, it must be 
obtained from the diet or synthesized from the precursor fatty acid, alpha-linolenic acid 
(ALA) (Sun et al., 2018).  Currently, fish oil is the major source of omega-3 DHA.  However, 
several drawbacks related to the use of fish oil as the source of omega-3 have been reported 
in the literature (Lane et al., 2014). Fish oil possesses undesirable odors, flavors and tastes 
which discourage consumers from consuming it in its pure form. Furthermore, fish oils are 
likely to contain high levels of methyl-mercury, heavy metals and antibiotics, creating a risk 
of poisoning the consumers. In addition, environmental contaminants such as dioxins, 
dichlorodiphenyltrichloroethane (DDT) and polychlorinated biphenyls have been found in 
fish oil, all of which discourage its use. Fish oil is also very expensive, thus, may not be 
afforded by majority of individuals in developing countries. In addition, the production of 
fish oil has reached the optimal threshold and is declining throughout the world.  In this view, 
there is a need to look for sustainable and safe sources of omega-3 DHA. 
Dietary ALA could be an alternative source of omega-3 DHA (Domenichiello et al., 2015). 
This is because human bodies can convert dietary ALA into omega-3 DHA and that the 
ALA-rich foods are almost found everywhere on this earth. Some of foods that are rich in 
ALA include walnuts, soybeans, flaxseeds, chia seeds, canola, and many other nuts and 
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seeds. Beans, legumes and wheat germ are also high in omega-3 ALA (Lenihan-Geels et al., 
2013).  Several foods and food products that are rich in ALA are available on the global 
market and are being advertised as food for brain development and cognitive function in all 
age groups. People believe that since human bodies can make DHA out of ALA, eating more 
omega-3 ALA foods would help them get enough DHA. Unfortunately, the body is not very 
good at turning omega-3 ALA into omega-3 DHA (Lane et al., 2014). The reasons to such 
inefficiency in ALA conversion are not clearly stated. However, some evidence show that 
poor levels of cofactors such as zinc, magnesium, vitamin C, proteins and B vitamins and too 
much omega 6 in the body slowdown the conversion rate of ALA into DHA (Saunders et al., 
2012).  
Although adequate levels of cofactors and the optimal ratio of omega-3 to omega-6 increase 
the conversion rate of ALA into DHA, the output of this conversion may not confer 
physiological benefits in the brain (Gillingham, 2013). Thus, individuals who solely depend 
on ALA-rich foods for their DHA are likely to be deficient in this important polyunsaturated 
fatty acid. The deficiency in DHA is very common among the individuals in developing 
countries, probably because they rely only on ALA-foods for their DHA. Evidence from the 
recent global estimates of dietary DHA shows that the vast majority of infants and young 
children in developing countries fall well short of the recommended intake (100 mg/day) of 
DHA omega-3 fatty acid (Forsyth et al., 2016). This highlights the need for setting a robust 




























Figure 2: Conversion of alpha linolenic acid (ALA) to docosahexaenoic acid (DHA) 
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1About 0-9% of ALA is converted to EPA and DHA. Source: (Lane et al., 2014) 
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2.6  Microalgae as an alternative source of bioavailable omega-3 DHA 
Since the conversion of ALA into DHA is quite inefficient, involving many desaturase and 
elongase enzymes, many researchers speculate that there could be benefits in providing pre-
formed DHA in the diet rather than relying solely on ALA. This is particularly challenging 
during fetal and neonatal development when demands for DHA in the central nervous system 
cannot readily be met by ALA alone (Sun et al., 2018). Researchers have further speculated 
that the primary source of food for fish could be the appropriate and sustainable source of 
dietary preformed DHA. This is because, even fish themselves cannot synthesize DHA de 
novo in their body (Dewick, 2009). They obtain their DHA from the foods they eat, normally 
phytoplankton (microalgae).  
Microalgae is the best alternative natural source of bioavailable omega-3 DHA and other 
essential nutrients such as iron, zinc, vitamin B3, vitamin B6, vitamin C, vitamin E and 
magnesium, some of which are cofactors for the conversion of ALA into DHA in the body. 
Because of this, microalgae have recently been pointed out by 130 national academies of 
science and medicine (as reported by AIP, 2018) as one of the innovative foods that can bring 
co-benefits to human health and climate in the near future. Increased consumption of 
microalgae will replace meat consumption in some regions and hence reduce emission of 
greenhouse gases that emanates from the meat. So, microalgae have multiple benefits such as 
promotion of nutrition and health, generation of income to smallholder farmers, and 
mitigation of climate change in developing regions like East Africa. 
2.7 Opportunities for future research around microalgae in East Africa 
A number of microalgae species have been identified across the globe. The typical largest 
homes of microalgae are Japan, the Philippines, China and South Korea, followed by 
Vietnam, Chile, and Eastern Africa (Tanzania in particular) (Rajauria et al., 2015). Unlike 
other countries, Eastern Africa has not yet fully exploited the potential of microalgae to 
improve nutrition and health in the region. So far, there is no scientific information regarding 
the nutritional and phytochemical profiles of microalgae found in the region. This limits 
practitioners from incorporating microalgae in nutrient-based interventions for improving 
status of omega-3 DHA among the individuals in the region. This stresses the need to identify 
microalgae species in the region and establish their scientific evidence in improving nutrition 
and health. This scientific information will help nutritionists and other health practitioners 
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develop formulations or products rich in preformed omega-3 DHA for prevention of mental 
health disorders in the region.  
A proper business model that can link microalgae smallholder farmers and processors is also 
needed in the region. This model is very important, as it will accelerate optimal utilization of 
microalgae in the region. Optimization tools like linear programming (LP) can be deployed to 
ensure keen execution of the model along the microalgae chain. Linear Programming is a 
mathematical tool which allows generation of optimal solutions that satisfy prescribed 
constraints at once (Dibari et al., 2012). The tool can be used to optimize production 
conditions for microalgae. It can also be used by microalgae processors to formulate products 
that are rich in preformed omega-3 DHA and other essential nutrients (Cahyaningrum et al., 
2016). The tool can also be used to inform regulatory authorities to design appropriate 





MATERIALS AND METHODS 
3.1 Formulation and testing of the product 
The overall process of formulating and testing the model formula involved three key phases. 
The first phase encompassed the identification of the target group and the desired 
composition of the formulation. After that, global and local food composition databases and 
published reports were used to identify potential ingredients and nutrient composition data. 
The second phase involved the activity of defining decision variables, constraints and 
objective function for the linear programming model. These parameters were used to set up 
and solve the LP model using a widely available software (Microsoft Excel Office 2013 and 
the Solver add-in). The third phase involved preparation and sensory testing of the model 
formulations in the food kitchen at NM-AIST laboratory. In this phase, the prepared 
formulations were also assessed for the feasibility of mixing in the laboratory and predicted 
the feasibility of full-scale production. 
3.1.1 Choice of food composition database  
Optimal formulation of this study relied a lot on accuracy of the food composition database 
that were selected. The selection was based on criteria set forth in a previous study (Dibari et 
al., 2012), which included;  
(i) The widest representation of commodity composition data from around the world 
(ii) The largest number of nutrient data values per food  
(iii) Food descriptors matching the selected ingredients   
(iv) Internationally respected datasets, ideally with methods cited in peer reviewed 
journals.  
The key food composition database identified include; Tanzania Food Composition Tables, 
United States Department of Agriculture National Nutrient Database, Canadian Nutrient 




3.1.2 Selection of potential ingredients  
In the selection process, a checklist of all potential ingredients that can be sourced or farmed 
in Tanzania was prepared. Thereafter, a final selection based on the nutrient content, local 
availability and acceptability of the local ingredients was made. Care was taken to include 
ingredients rich in preformed omega-3 DHA, high quality protein and other essential 
nutrients like zinc, magnesium, niacin, vitamin B6, vitamin C and vitamin E that favor 
conversion of ALA to DHA. Microalgae, golden berries, pumpkin seeds and sesame seeds 
are some of the key ingredients that were chosen as they are very rich in health promoting 
compounds, and can be sourced locally in Tanzania and other Eastern Africa countries. 
Microalgae for instance, are rich in preformed Omega-3 DHA and other essential nutrients. 
The nutritional information for each ingredient was collected from the following sources; the 
USDA Nutrient Database, Tanzania Food Composition Tables, Canadian Nutrient File, 
Danish Food Composition Database - Frida version 3 and SCI peer reviewed journals. 
3.1.3 Setting up and running the LP model 
Optimal formulation was designed to satisfy several pre-stated conditions (constraints), 
which were derived from UN specifications set for ready to use therapeutic foods. Some of 
these constraints include; energy and nutrient concentration, palatability, texture, total food 
ingredient weight, and the ratios of protein, fat and essential fatty acids to energy. The LP 
tool was set to consider minimization of cost as the objective function. The linear objective 
function for this study was expressed as follows; 
 
(1) 
where Y is the total cost of ingredients, bi is the cost per 1g of ingredients i, and Bi is 
the amount of ingredient i as described in the previous study (Brixi, 2018). 
Energy and nutrient concentration constraints. The LP constraints were introduced to ensure 
that the formulation met the international standards for energy density and the ratios of 
protein, fat and essential fatty acids to energy. Care was taken to ensure that the energy 
density is equal to 500 kcal/100 g, and caloric distribution to be 45% to 50% from fat and 
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10% to 12% from protein as per international specifications (UNICEF, 2013). Furthermore, 
constraints were introduced to ensure that the optimal formulation contains an elevated level 
of preformed Omega-3 DHA+EPA and other essential nutrients. Protein digestibility 
corrected amino acid score (PDCAAS) was also calculated and constrained to ensure protein 





where Qa is total quantity of essential amino acid a, Ci is quantity of ingredient i, ai is 
quantity of amino acid a per 1 g of ingredient i, di is protein digestibility factor of 
ingredient i, P is total quantity of protein in the formula, and ga is goal quantity of 
amino acid a per 1 g reference protein. 
 Palatability constraint was also introduced in the LP model to ensure acceptable tastes of the 
optimal formulation. In this design, dried golden berries were included in the formulation to 
serve a purpose of sweet taste. As for the texture related constraints, a paste-like property was 
considered as a suitable consistency and texture of the formulation. This is because paste 
texture property can be squeezed easily into the mouth by children or by their caregivers. 
Particle size and fat composition was constrained as they can significantly affect the texture 
quality of the formulae.  
Once the formulation was shown to be acceptable (as described in a subsequent section on 
the preparation of prototype formulation), the total food ingredient weight was constrained to 
allow a sufficient space for inclusion of vitamin and mineral fortificant for severely 
malnourished children. In this exercise, an equality constraint was deployed to fix the weight 
of the formulation at 97-100 g. This setting is based on previous calculations which showed 
that up to 3% of the final product weight might be required for the premix nutrients (Ryan et 
al., 2014). 
The LP model and the software. The process of running the LP model consisted of: (a) 
creation of the data layout on a Microsoft Excel spreadsheet; (b) activation of add-in Solver 
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Function, which is supplied with standard installations of Excel; (c) assignment of the 
objective function (OF), decision variables and constraints; (d) running the LP procedure to 
solve the OF; and (e) a sensitivity analysis. Steps (a) to (c) were applied following the 
procedure described elsewhere (Dibari et al., 2012). 
3.1.4 Preparation of prototype formulations 
Prototype formulations were prepared at the NM-AIST laboratory kitchen. The preparation 
underwent different steps, including; roasting of some ingredients, particle size reduction, 
homogeneous blending, and packaging. In the present exercise, qualitative questions, such as 
“can this formulation be mixed with a counter-top mixer? A food processor? A blender?” and 
“Is it possible for this formulation to be mixed in a bakery mixer? In a ribbon blender? Or 
other mixing equipment?” were answered for each formulation as described in a previous 
study (Ryan et al., 2014). Anti-nutritional factors, anticipated ingredient interactions and 
sensory attributes were also assessed qualitatively. Based on these assessments, 10 
formulations were prepared in the laboratory kitchen. Individuals familiar with ready to use 
therapeutic foods then tasted all 10 prepared formulations informally. Basic tastes were rated 
informally on a 9-point hedonic scale. The two most promising formulations were chosen and 
informally evaluated for sensory attributes by three independent experienced nutritionists 
who then proposed one novel formulation as an alternative to typical ready to use therapeutic 
foods in the developing world. 
3.2 Laboratory analysis of the prototype formulation 
3.2.1 Proximate composition analysis  
Proximate analysis of the prototype was carried to determine moisture content, crude protein 
content, crude fat content, crude fiber content, ash content and carbohydrate content as 
described below; 
(i) Moisture content 
Moisture content was determined using a published standard method of Asean manual of 
food analysis of 2011. Sample was dried in an oven at controlled temperature to constant 
weight. Into a cleaned, dried and weighed glass crucible, 5 g of the dried sample was 
weighed. Then, the crucible with the content was further dried at 103 ℃ for 12 hours in the 
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oven. The sample had to be cooled in a desiccator and re-weighed. The weight loss 
(expressed as a percentage of the initial weight of the sample) gives the amount of moisture 
in the sample (equation 4). 
 
where:  W1= weight of crucible (g)  
W2= weight of crucible + sample before drying (g)  
W2 - W1 = weight of sample (g) 
W3 = weight of crucible + sample after drying (g) 
W2 – W3 = loss of weight (g). 
(ii) Crude protein content 
Crude protein was determined by the method of the Association of Official Analytical 
Chemists (AOAC) as described by (Eshun et al., 2013). Briefly, 2 g of the sample was 
weighed into a digestion flask. 0.5 g of selenium catalyst was added, followed by 25 ml of 
conc H2SO4, then the flask was shaken to mix the contents. The contents were heated for 8 
hours until the solution turned green and clear. The sample solution was then transferred into 
a 100 ml volumetric flask and made up to the mark with distilled water. Into a 250 ml conical 
flask, 25 ml of 2% boric acid was pipetted and two drops of mixed indicator (20 ml of 
bromocresol green and 4 ml of methyl red) solution were added; followed by the addition of 
15 ml of 40% NaOH solution into the decomposition chamber of the distillation apparatus. 
Then, into a Kjedahl flask, 10 ml of the digested sample solution was introduced, and then 
the condenser tip of the distillation apparatus was dipped into the boric acid. Distillation of 
ammonia in the sample solution was done into the boric acid until it turned completely to 
bluish green. Titration of the distillate was done using 0.1 N HCl solution, until it turned 
colorless. A conversion factor of 6.25 was used to calculate the total percent of nitrogen and 
crude protein as shown in equation 6. Point to note is that in every batch of analysis, a blank 





(iii) Crude fat content 
Crude fat was determined based on the Sohxlet extraction method of Association of Official 
Analytical Chemistry described in the Asean manual of food analysis of 2011. Briefly, a 250 
mL quick fit round bottom flask was washed and dried in an oven at 103 ℃ for 25 minutes, 
left to cool to room temperature and then weighed. Into a muslin thimble, 2 g of the sample 
was weighed, and the thimble was inserted into the extraction column where the condenser is 
connected. Thereafter, into the round bottomed flask, 200 ml of the extracting solvent 
(petroleum ether, boiling point 40 to 60 ℃) was poured and fitted into the extraction unit. 
With the aid of electro thermal heater, the flask was heated at 60 ℃ for 2 hours.  
The condenser was used to cool and reflux the evaporated solvent due to heating. After the 
extraction process, the thimble was removed and the solvent was recovered by distillation. To 
evaporate the solvent, the flask containing fat and the residual solvent was placed on a water 
bath and further dried in an oven at 103 ℃ for 30 minutes to entirely remove the solvent. The 
flask was then cooled in a desiccator and re-weighed. The amount of fat obtained was 
expressed as a percentage of the initial weight of the sample as described in equation 7. 
 
where:  W1= weight of sample 
W2= weight of dried flask before fat extraction 
W3 = weight of dried flask after fat extraction 
(iv) Crude fiber content 
Fiber was determined by the method of Association of Official Analytical Chemists (AOAC) 
described in a previous study with little modification (Eshun et al., 2013). The defatted 
sample (from crude fat determination) was transferred into a 750 ml Erlenmeyer flask and 0.5 
g of asbestos was added. Thereafter, 200 ml of boiling 1.25% s H2SO4 was added and the 
flask was immediately set on a hot plate and condenser connected to it. The content was 
brought to boil within 1 minute and the sample was digested for 30 minutes. 
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At the end of 30 minutes, the flask was removed and the content was filtered through a linen 
cloth in a funnel and subsequently washed with boiling water until the washings were no 
longer acidic. The sample was washed back into the flask with 200 ml boiling 1.25% sodium 
hydroxide solution. The condenser was again connected to the flask and the content of the 
flask was boiled for 30 minutes. It was then filtered through the linen cloth and thoroughly 
washed with boiling water until the washings were no longer alkaline. The residue was 
transferred to a clean crucible with a spatula and the remaining particles washed off with 15 
ml ethanol into the crucible. 
The crucible with its content was then dried in an oven overnight and cooled in a desiccator 
and weighed. The crucible with its content was then ignited in a furnace at 600 ℃ for 30 
minutes, cooled and reweighed. The loss in weight gave the crude fiber content and was 
expressed as a percentage of the initial weight of the sample. 
(v) Ash content 
Ash was determined by the method of Association of Official Analytical Chemists as 
(AOAC) described in the Asean manual of food analysis of 2011. Briefly, about 2.0 g of 
sample was weighed into a dried and weighed porcelain crucible. The crucible with its 
content was placed in a furnace preheated to 600 ℃ for 2 hours. The sample was allowed to 
cool in the furnace to 250 ℃. The crucible and the ash were then transferred into an oven at 
100 ℃ for 30 minutes cooling. After this period, the crucible with its content was cooled in a 
desiccator. The crucible with its content was weighed. The weight of the ash was expressed 
as a percentage of the initial weight of the sample. 
 
where:  W1= weight of crucible 
W2= weight of crucible + sample 
W3= weight of crucible + ash 
(vi) Carbohydrate content 
Total percentage carbohydrate was determined based on the method reported previously 
(Eshun et al., 2013). In this method, carbohydrate content was determined by subtracting the 
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total values of protein, fat, fiber, moisture and ash constituents of the sample from 100 as 
expressed in equation 9 below.  
 
3.2.2 Mineral analysis 
Analysis of minerals was done according to the previous method (Altun et al., 2017). Briefly, 
100 g of sample were dissolved in nitric acid for acid digestion and ultra-pure water was 
added to the solution until the volume reached 100 ml. Then after, Inductively Coupled 
Plasma Mass Spectrometry (ICP-MS) was used to profile the mineral composition of the 
sample. The glass-ware was cleaned with % 10 (v/v) HNO3 solution for one day and rinsed 
with ultrapure water. About 1.0 g of the sample was digested with 4.0 mL of 65% (v/v) 
HNO3 and 0.5 mL of 35% (v/v) H2O2 in PTFE vessels. The vessels were placed into 
microwave system. A blank digest was carried out in the same way. Digestion conditions for 
the microwave system applied were as follows: up to 120 ℃ for 15 minutes and then constant 
for 10 minutes; up to 160 ℃ in 20 minutes and constant for 15 minutes; finally, a cooling 
stage (30 minutes) was carried out to 22 ℃ and diluted to 50 mL with deionized ultrapure 
water. This solution was finally used for minerals analysis, performed with an ICP-MS. The 
concentrations of nine elements (sodium, potassium, calcium, phosphorus, magnesium, iron, 
zinc, copper and selenium) were then determined in the sample. The digested sample was 
analyzed in duplicate and measured in triplicate by ICP-MS detection. All reagents were of 
analytical grade. 
3.2.3 Water soluble vitamins analysis 
Analysis of water soluble vitamins (B vitamins and vitamin C) was done as follows: 
(i) B vitamins 
Extraction for vitamins analysis was done according to a method described previously (Sami 
et al., 2014). Briefly, about 2 g of the sample was placed in 25 mL of H2SO4 (0.1 N) solution 
and incubated for 30 minutes at 121 oC. The contents were cooled and adjusted to pH 4.5 
with 2.5 M sodium acetate, and 50 mg Takadiastase enzyme was added. The preparation was 
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stored at 35oC overnight. The mixture was then filtered through a Whatman No.4 filter, and 
the filtrate was diluted with 50 mL of pure water and filtered again through a micropore filter 
(0.45 µm). Twenty microliters of the filtrate were injected into the HPLC system. 
Quantification of vitamin B content was accomplished by comparison to vitamin B standards. 
Standard stock solutions for thiamine, riboflavin, niacin, vitamin B6, vitamin B12, Folate, 
pantothenic acid and choline were prepared according to standard methods reported 
previously. Chromatographic separation was achieved on a reversed phase- (RP-) HPLC 
column through the isocratic delivery mobile phase at a flow rate of 0.5 mL/minute. 
Ultraviolet (UV) absorbance was recorded at 270 nm at room temperature. 
(ii) Vitamin C 
For vitamin C, 10 g of the sample was blended and homogenized with an extracting solution 
containing metaphosphoric acid (0.3 M) and acetic acid (1.4 M) as reported by Sami et al. 
(2014). The mixture was placed in a conical flask and agitated at 10 000 rpm for 15 minutes. 
The mixture was then filtered through a Whatman No.4 filter, and samples were extracted in 
triplicate. The ascorbic acid standard was prepared by dissolving 100 mg of L-ascorbic acid 
in a metaphosphoric acid (0.3 M)/acetic acid (0.4 M) solution at a final concentration of 0.1 
mg/Ml. The calibration line was converted to a linear range based on four measured 
concentration levels. Quantification of ascorbic acid content was performed on an Agilent 
HPLC system. Chromatographic separation was achieved on an RP-HPLC column through 
isocratic delivery of a mobile phase at a flow rate of 1mL/minute. UV absorbance was 
recorded at 254 nm at room temperature. 
3.2.4 Fat soluble vitamins analysis 
Analysis of fat soluble vitamins were done according to the previous method (Sami et al., 
2014). Briefly, in 10 g of the sample, 1 g of pyrogallic acid, 70 mL ethanol and 30 mL (50%) 
KOH were added, stirred, and refluxed for 40 minutes using a water bath at 50 ± 2 ℃. 
Extracts were obtained three times using various ether concentrations (50 mL, 30 mL and 20 
mL). Double-distilled water was used to neutralize the extract, which was dehydrated using 
anhydrous sodium sulfate. Further, the extract was concentrated to approximately 5 mL by 
using a water bath (50 ± 2 ℃), diluted to 10 mL by using methanol, filtered using a 0.45 𝜇m 
membrane, and finally subjected to HPLC analysis. 
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The HPLC analysis was performed with the Agilent 1100 series HPLC system (Agilent; 
USA), including a diode array detector. The column was made of stainless steel. The Agilent 
Eclipse XDB-C18 column was used (5 𝜇m, 4. 6 × 150 mm), and the solvent was methanol. 
The UV detection was recorded at 325 nm for vitamin A, 290 for vitamin E and 244 nm for 
vitamin K. Separation of all vitamins was based on isocratic elution and the solvent flow rate 
was maintained at 1 Ml/minute. About 20 microliters of the sample oil were directly injected 
into the HPLC column. Fat-soluble vitamins were identified by comparing their retention 
times with those authentic standards. All procedures were carried out under subdued light 
conditions. 
Standard solutions of vitamins were prepared by serial dilution to concentrations of 1, 2, and 
5 mg per liter of vitamins E, K and A, respectively. Standard solutions were prepared daily 
from a stock solution, which was stored in the dark at -20 ℃. Thereafter, 20 microliters of 
standard solution were injected, and peak areas were determined to generate standard curves. 
3.2.5 Fatty acids analysis 
Analysis of fatty acids was based on a previously published method (Kchech, 2017). About 
150 mg of the sample were dissolved in 0.5 N methanolic sodium hydroxide and heated on a 
steam bath. Then after, 5 ml of BF3 methanol were added to the solution and the mixture was 
boiled. To float the methyl esters up, enough of saturated sodium chloride was added to the 
solution. The solution was left to cool at room temperature and distilled water was added 
followed by the addition of n-hexane. The solution was then transferred into a separating 
funnel and left to settle until a clear separation between the organic phase and the aqueous 
phase was visible. The aqueous layer was drained first into a conical flask. The organic layer 
was transferred to the second conical flask followed by the addition of anhydrous sodium 
sulfate to remove any trace of water in the organic layer. The methylated fatty acids 
contained in n-hexane was then transferred to vials and nitrogen gas was blown to remove 
hexane. 
The vials were placed on a liquid auto-sampler and a 1.0 μL injection of the prepared sample 
was introduced into the GC using 10.0 μL Agilent syringe. The syringe was washed prior to 
each injection with one portion of ethyl acetate, and one portion of dichloromethane. The 
injection was introduced into an Agilent single tapered splitless liner containing glass wool at 
240 ℃. The GC separation was accomplished using an Agilent Technologies 6890 N 
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Network GC System containing an Agilent J & W GC column, DB-5MS; with a length of 30 
m, diameter of 0.250 mm and film of 0.25 μm. The carrier gas was helium with a constant 
flow of 1.4 mL/minute. The initial oven temperature was held at 45 ℃ for 5 minutes, 
increased at 10 ℃ for a final temperature of 320 ℃ and held at 5 minutes. The transfer of the 
sample to the detector was done through a transfer line that was kept at 300 ℃. The detector 
used for performing the analysis was mass spectrometer that had a relative electron impact 
ionization (EVI) at 70 eV, source temperature of 230 ℃ and a quadrupole temperature of 150 
℃. The total runtime was 37.5 minutes with an initial solvent delay of 6.50 minutes with a 
scan range from m/z 60-600 at a normal scan speed with a rate of 2.71 scans per second. The 
concentration of methylated fatty acids in the sample was calculated based on the normalized 
peak area and the equations obtained by the calibration curves. 
3.2.6 Amino acids analysis 
Amino acid profile was determined using HPLC-florescent detection method (Dayal et al., 
2011). Briefly, the amino acid composition was analyzed after sealed tube hydrolysis with 6 
N HCl for 22 hours at 110 ℃. After the hydrolysis, the acid was evaporated in a vacuum oven 
and the sample was kept in NaOH dessicator to remove traces of acid. The residue was 
brought in to 1 ml of Sodium Citrate-Perchloric acid sample diluent (pH 2.20) and filtered 
through 0.2 µm membrane filter. Separation of amino acids was done in a column packed 
with a strongly acidic Na+ type cation exchange resin (Styrene-divinyl benzene copolymer 
with sulfinic group) under gradient elusion at a flow rate of 0.3 ml/minute by using two 
buffers, (A) sodium citrate-perchoric acid (pH 3.2); (B) boric acid sodium citrate-sodium 
hydroxide (pH 10.0). The amino acids were quantified using a fluorescent detector after post 
column derivitization with O-pthaladehyde and 2-mercaptoethanol. Amino acid standard 
solution for fluorescent detection was used as external standard. 
3.3 Relative difference of the LP calculated values and the Lab analyzed values  
The relative difference of the LP calculated values and the lab analyzed values was calculated 
based on the method described by Dibari et al. (2012). In this method an absolute difference 
for each nutrient was calculated by subtracting the LP calculated values from lab analyzed 
values. Thereafter, the relative difference was calculated by dividing the absolute difference 
values over the LP calculated values as shown in equation 10. The relative difference was 




where:  A= LP calculated values 
B= Lab analyzed values 
C= Absolute values (B-A). 
3.4 Sensory evaluation of the final product 
Sensory evaluation test was conducted to determine the degree of consumer acceptability of 
the formulated ready-to-use food. The hedonic test was conducted among mothers or primary 
caregivers. The assumption was that mothers or primary caregivers are more likely to decide 
on what a child should eat at household level. Inclusion criterion was that a mother or 
primary caregiver must have a child aged between six months and 10 years and is willing to 
participate in the experiment. The number of respondents who turned up for this experiment 
was 50. The acceptance of sensory attributes of the formulated food product was evaluated 
using a nine-point hedonic scale as described by Megido et al. (2016). The scale ranges from 
“extremely dislike” to “extremely like”, where 1= like extremely, 2= like very much, 3 = like 
moderately, 4=like slightly, 5=neither like nor dislike, 6= dislike slightly, 7= dislike 
moderately, 8= dislike very much, 9= dislike extremely with respect to color, odor, taste and 
texture. Respondents were instructed orally to neutralize any taste (drink water) before the 
actual sensory evaluation test. Thereafter, each respondent was given a product for hedonic 
test. Their responses were recorded and coded for statistical analysis.  
3.5 Assessment of willingness to pay (WTP) 
The WTP was elicited using Becker-DeGroot-Marschak (BDM) method as described in 
previous studies (Adams et al., 2016; Lybbert et al., 2016). Briefly, primary caregivers were 
asked if they are willing to pay specific, incrementally-increasing prices for the modelled 
ready-to-use formula (100 g) to feed their children. Once a participant indicates, s/he is not 
willing to pay a specific price, his/her maximum WTP was recorded as the previous price in 
the series. The auctions were grouped in 10 sessions. Each session comprising somewhere 
between four to six participants. In each session, participants were asked to confidentially 
bid the price they are willing to pay for 100 g of ready-to-use formula to their assigned 
enumerator. The session was managed by the same facilitator to ensure similarities of the 
experiment as possible. During the auctions, the facilitator provided the nutritional and 
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health benefits of the product so that caregivers can provide informed decision regarding 
their WTP. The information that was provided to each session was the potential short-term 
benefits as well as long-term benefits of omega-3 DHA and other essential nutrients on 
brain development and cognitive function of a child, focusing on schooling attainment and 
economic productivity in adulthood. The experiment of WTP was done immediately after 
the sensory evaluation of the product. 
3.6 Statistical analysis 
Paired sample t-test was used to compare the average nutritional values between the LP 
calculated values and the laboratory analyzed values. The aim of this statistical test was to 
check whether the nutritional values of the formulated product and those from LP were 
statistically different at p=0.05. on the other hand, a Kruskal-Wallis H test was used to 
determine if there are statistically significant differences between sensory attributes (such as 
color, odor, taste and texture) of the product on a nine-point hedonic likert scale scores at 
p=0.05. Furthermore, in order to understand the determinant of WTP in the sample 
population, generalized linear model (GLM) was used to estimate the bid price while 
controlling for potential confounding factors. In the analysis, socio-economic factors (such 
as education, household size, annual income and occupation) and sensory attributes scores 
with respect to color, odor, taste and texture of the product were incorporated. Data were 
processed and coded in IBM SPSS version 21. All analyses and plots were carried out in 





RESULTS AND DISCUSSION  
4.1 Results 
4.1.1 Attributes of the final product 
Optimal RUF formulae rich in preformed omega-3 DHA and EPA was developed using 
linear programming (LP) method. The formulation was based on ingredients that can be 
sourced locally in Tanzania and East Africa at large. Microalgae powder, dried fruits and 
roasted oily seeds were the common ingredients the LP tool selected to generate the optimal 
RUF formulae. Most of macronutrient and micronutrient contents in the proposed RUF were 
similar to the standard RUF (Table 1). For example, protein-energy ratio (0.19), fat-energy 
ratio (0.55), (n-3) fatty acids-energy ratio (0.003), (n-6) fatty acids-energy ratio (0.03) and the 
total energy content (524 kcal) of the optimized RUF formulae matched the UN standards.  
The optimized RUF formulae contained high concentration (220 mg/100 g) of preformed 
omega-3 DHA and EPA. Similarly, the optimized RUF formulae contained a significant 
amount of natural cofactors required for the conversion of omega-3 ALA into omega-3 DHA 
in the body. In addition, the optimized RUF formulae contained a relatively well-balanced 
omega-6 to omega-3 fatty acids (2.5:1) ratio compared to the commonly used RUFs. The 
optimized formulae also achieved the UN standards for phytic acid to iron ratio, phytic acid 
to zinc ratio, calcium to phosphorus ratio and zinc to copper ratio which are determinants of 
mineral absorption in the body.  In view of protein quality, the optimized RUF formulae 
achieved  more than 95% protein digestibility corrected amino acid score (PDCAAS) (Table 
1).  
Likewise, the total cost of the proposed optimized RUF formulae was more than 50% lower 
than the estimated ingredient cost of the currently used Plumpy’nut formulae. Ingredient cost 
reduction in the optimized RUF formulae is largely driven by the replacement of milk powder 
and peanuts. The main cost savings generated in the optimized RUF formulae for Tanzania 
stem from the removal of milk powder, as well as from the low local price of local 
ingredients. The cost for main ingredient in the optmised formulae was about USD 0.04 for 
microalgae powder and dried fruits, USD 0.05 for sesame seeds and USD 0.06 for pumpkin 
seeds, all of which are locally available in the country.  
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4.1.2 Relative difference between LP calculated values and lab analyzed values 
Paired sample t-test analysis showed that there was no statistical significance difference 
(p=0.102) between the LP calculated nutrient values and the laboratory analyzed nutritional 
values of the formulated product. The relative differences in the nutritional values between 
the LP calculated values and lab analyzed values are described in Table 2.  
4.1.3 Characteristics of respondents participated in the study 
Sixty primary caregivers participated in the sensory evaluation and willingness to pay 
experiments for the formulated ready-to-use food for children. All caregivers had children 
aged between 6 months and 10 years. Most common caregivers were mothers with a mean 
age of 28 years. About half of the studied households had more than five members and 33.5% 
of children had another sibling under 5 years of age. About half of primary caregivers had 
formal primary education, whereas more than one-third (35%) of the caregivers had no 
education at all. Most of primary caregivers were peasants engaged in subsistence crop 
farming. Table 4 summarizes the characteristics of the respondents who participated in the 
sensory evaluation and WTP experiment. 
4.1.4 Sensory evaluation and willingness to pay results 
For sensory testing, a Kruskal-Wallis H test showed that there was no statistically significant 
difference likert scale score between the sensory attributes of the ready-to-use product, with a 
mean likert scale score of 2.15 for color, 2.24 for taste, 2.31 odor and 2.14 for texture at 
p=0.05. Descriptive analysis showed that about 80%, 81%, 84% and 80% liked the product 
very much for color, taste, odor and texture, respectively. The average score for overall 
acceptability of the formulation was approximately 2.0 (“like very much”). 
For WTP, on average, individuals were willing to pay at least US$ 0.15 for the formulated 
ready-to-use food. The generalized linear model (GLM) analysis showed that annual income 
and product sensory attributes were not able to predict the WTP at the 5% level (Table 5).  In 
contrast, the GML model results showed that caregiver’s education status was the most 
significant predictor of WTP for the product. The bid price increased with education, 




Table 1: Nutrient composition of the proposed optimized RUF formulae (per serving) 
  Component 
RUF optimized 
(100 g) 
Plumpy’nut1  (92 g) 
UN Standards 
(100 g) 
Moisture, g 3.4 2.9 <8 
Energy, kcal 524 544 520–560 
Protein, g 26 16.6 14.5–19.0 
Fat, g 32 36 26.8–36.3 
Ash, g 4.0 3.8 0.3–4.0 
Carbohydrate, g 33 40.7 41–58 
Added sugar, g — 20.5 ≤25 
Fiber, g 9.9 4.8 <5 
Sodium, mg 226 52.2 <290 
Potassium, mg 1080 1070 1100–1400 
Calcium, mg 315 399 300–600 
Phosphorus, mg 592 493 300–600 
Magnesium, mg 304 119 80–140 
Iron, mg 15 31.6 20–25 
Zinc, mg 7.0 19.9 18–23 
Copper, mg 1.5 1.5 1.4–1.8 
Selenium 20 25 20–40 
Vitamin A, mg RE 0.92 1.16 0.8–1.2 
Vitamin E, mg 3.0 39 0.2 
Vitamin K, mg 22 12 15–30 
Thiamin, mg 0.8 1.12 >0.5 
Riboflavin, mg 0.9 1.97 >1.6 
Vitamin C, mg 22 306 290–360 
Vitamin B-6, mg 0.35 0.93 >0.6 
Vitamin B-12, mg 12.7 2.6 >1.6 
Folate, mg 63 200 0.2 
Niacin, mg 6.0 7.94 0.5 
Pantothenic acid, mg 0.96 4.73 0.3 
Choline, mg 31 70 — 
n–3 Fatty acids, % TE 0.3 0.18 0.3–2.5 
n–6 Fatty acids, % TE 3.0 3.91 3.0–10.0 
n–3 (DHA+EPA), mg 220 – – 
SFAs, g 5.0 15.5 — 
MUFAs, g 9.8 12.6 — 
PUFAs, g 12.2 4.09 — 
trans Fat, g 0.05 0.18 <3% total fat 




Phytic acid: iron 0.003 0.89 <2.5 
Phytic acid: zinc 0.006 1.66 <15 




Ascorbic acid: iron 2.0 9.68 3.0–16.0 
Calcium: phosphorus 1.0 0.81 1.0–1.5 
Zinc: copper 5.0 13.27 5.0–20.0 
Zinc: iron 0.5 0.63 0.8–3.5 
PDCAA, % 100 ≥95 — 
Total ingredient price (USD) 0.15 0.30 — 




Table 2: Relative difference of the LP calculated values and the Laboratory analyzed 
values 
Component LP calculated values Lab analyzed values 1A.D 2R.D 
 
A B B-A=C (C/A) x100 
Moisture, g 3.4 3.5 0.10 2.94 
Energy, kcal 524 523 -1.00 -0.19 
Protein, g 26 25 -1.00 -3.85 
Fat, g 32 33 1.00 3.13 
Ash, g 4.0 4.1 0.10 2.50 
Carbohydrate, g 33 32 -1.00 -3.03 
Added sugar, g — — — — 
Fiber, g 9.9 10 0.10 1.01 
Sodium, mg 226 226 0.00 0.00 
Potassium, mg 1080 1080 0.00 0.00 
Calcium, mg 315 312 -3.00 -0.95 
Phosphorus, mg 592 590 -2.00 -0.34 
Magnesium, mg 304 304 0.00 0.00 
Iron, mg 15 15.5 0.50 3.33 
Zinc, mg 7.0 7.2 0.20 2.86 
Copper, mg 1.5 1.55 0.05 3.33 
Selenium 20 20.5 0.50 2.50 
Vitamin A, mg RE 0.92 0.95 0.03 3.26 
Vitamin E, mg 3.0 3.1 0.10 3.33 
Vitamin K, mg 22 21 -1.00 -4.55 
Thiamin, mg 0.8 0.83 0.03 3.75 
Riboflavin, mg 0.9 0.94 0.04 4.44 
Vitamin C, mg 22 22.8 0.80 3.64 
Vitamin B-6, mg 0.35 0.36 0.01 2.86 
Vitamin B-12, mg 12.7 13 0.30 2.36 
Folate, mg 63 61 -2.00 -3.17 
Niacin, mg 6.0 6.2 0.20 3.33 
Pantothenic acid, mg 0.96 1 0.04 4.17 
Choline, mg 31 30 -1.00 -3.23 
n–3 Fatty acids, % TE 0.3 0.3 0.00 0.00 
n–6 Fatty acids, % TE 3.0 3 0.00 0.00 
n–3 (DHA+EPA), mg 220 222 2.00 0.91 
SFAs, g 5.0 5.1 0.10 2.00 
MUFAs, g 9.8 10 0.20 2.04 
PUFAs, g 12.2 12.3 0.10 0.82 
Trans Fat, g 0.05 0.051 0.00 2.00 
Phytic acid, g 0.44 0.45 0.01 2.27 
Molar ratio 
 
   
Phytic acid: iron 0.003 0.003 0.00 0.00 
Phytic acid: zinc 0.006 0.006 0.00 0.00 
Ascorbic acid: iron 0.46 0.46 0.00 0.00 
Weight ratio 
 
   
Ascorbic acid: iron 2.0 2 0.00 0.00 
Calcium: phosphorus 1.0 1 0.00 0.00 
Zinc: copper 5.0 5 0.00 0.00 
Zinc: iron 0.5 0.5 0.00 0.00 
PDCAA, % 100 98 -2.00 -2.00 
1AB; absolute difference 





Table 3: Amino acid profile of the study RUF obtained by laboratory analysis  
Amino acid RUF optimized, g/100 g Plumpy’nut1, g/100 g 
Cystine 0.27 0.18 
Methionine 0.46 0.25 
Aspartic acid 1.90 1.39 
Threonine 0.70 0.54 
Serine 1.09 0.82 
Glutamic acid 4.10 3.01 
Glycine 1.24 0.53 
Alanine 0.99 0.52 
Valine 1.05 0.71 
Isoleucine 0.84 0.60 
Leucine 1.56 1.20 
Tyrosine 0.74 0.56 
Phenylalanine 1.11 0.72 
Lysine 0.77 0.93 
Histidine 0.53 0.37 
Arginine 3.34 1.01 
Proline 0.87 1.07 
Tryptophan 0.40 0.20 





Table 4: Socio-demographic characteristics of respondents 
Variable Variable description 









Proportion of  respondents who are 
head of households 
6 (10%)  
Household 
size 
Number of people living in the 







Married 49 (82%)  
 Single 5 (9%)  
 Widowed 2 (3%)  
 Separated 4 (6%)  
Caregivers 
education 
Illiterate 21 (35%)  
 Primary 30 (50%)  
 Secondary 7 (12%)  
 Tertiary  2 (3%)  
 
Table 5: Generalized Linear Model (GLM) for the WTP of the food product 
Variable Estimate 95% CI P-value 
Intercept 2.01E+03 1243 to 2779 < 0.05 
Annual income 2.95E-05 -3.0E-05 to 9.0E-05 0.35 
Color of the product 2.15E+02 -167 to 597 0.28 
Taste of the product -4.74E+01 -387 to 293 0.76 
Odor of the product -4.46E+01 -424 to 334 0.83 
Texture of the product -1.89E+01 -230 to 192 0.84 
Age of respondent -1.90E+01 -42 to 4 0.12 
Education of the respondent 1.53E+02 17 to 289 0.04 
Household size -1.49E+01 -85 to 56 0.66 
Occupation of the respondent -1.28E+01 -69 to 44 0.63 
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4.2 Discussion  
This study has shown that local ingredients other than fish oil (if optimized) can ensure 
dietary adequacy of bioavailable omega-3 DHA and other health promoting compounds 
among individuals in East Africa. In the present study, linear programming was used to 
formulate an alternative ready to use therapeutic foods based on locally available and 
culturally acceptable ingredients rich in omega-3 and other essential nutrients. The LP 
analysis indicated that it is technically feasible to design an internationally acceptable 
formulation rich in preformed omega-3 DHA and other health promoting compounds. The 
key ingredients in the formulations were pumpkin seeds, sesame seeds, golden berries and 
microalgae, all of which can be farmed locally by smallholder farmers in Tanzania. The 
ingredients were processed and rationed in a way that the formulation favors bioavailability 
of most limiting essential nutrients and bioactive health promoting compounds. For example, 
all oilseeds were roasted prior to the grinding into paste, as the use of raw non-roasted 
ingredients could lead to the presence of potentially high levels of anti-nutritional factors and 
phytates (Agume et al., 2017). The ingredients were then rationed in a way that a consumer 
should get adequate amount of preformed omega-3 DHA and EPA from a single serving of 
the formulation. The formulation was also designed to favor dietary adequacy of vitamin B3, 
vitamin B6, vitamin C, vitamin E, magnesium and zinc, which are cofactors for the 
conversion of ALA into DHA in the body. So, consumers will have an advantage of getting 
preformed DHA direct from the formulation and the DHA from ALA conversion in the body. 
Consumers will also have the advantage of getting (from the formulation) high potent lysine, 
threonine, methionine, tryptophan, vitamin A and iron which are the most limiting nutrients 
in developing world (Bailey et al., 2015; FAO, 2013).  
The analysis of this study has further shown that one serving of the present prototype 
formulation can provide about 220 mg of omega-3 DHA and EPA. This amount is enough to 
meet a daily recommended intake of omega-3 DHA and EPA for children aged between 2-10 
years (FAO, 2010), the very age group that needs DHA and EPA for brain development and 
mental health. Also, the analysis showed that the present formulation is far better than the 
most commonly used ready to use therapeutic foods, such as Plumpy’nut and Plumpy’doz 
when it comes to composition of essential compounds (such as DHA and EPA) for mental 
health and cognitive development. Most of commonly used ready to use foods that are 
imported to Africa contains negligible or no preformed omega-3 DHA and EPA (Brixi, 
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2018). This means that the present formulation from locally available ingredients can replace 
Plump’nut when it comes to nutrients and bioactive compounds that are needed for brain 
development and mental health. Furthermore, the balance of omega-6 and omega-3 fatty 
acids (2.5:1) in the present formulation is within the ratio that can support development of 
neural tissues (Yehuda, 2003). This ratio further makes the present formulation superior over 
most commonly used ready to use therapeutic foods, which in most cases, their omega 6 to 
omega 3 ratios are not within the recommended balance. Basically, an ideal ratio of omega 6 
to omega 3 ratio for most people is 4:1 – that's 4 omega-6s for every 1 omega-3 (Yehuda, 
2003). Conversely, nutritionists and anti-aging experts suggest that the ratio should go even 
further, maintaining a 1:1 ratio or higher in favor of omega 3s. Unlike commonly used ready 
to use foods, the present formulation contains essential fatty acids from non-animal sources. 
Microalgae is a major source of preformed omega-3 fatty acids in the present formulation. 
This makes the present formulation a future promising product for all consumers including 
vegetarians, especially in areas with high episode of mental health illnesses.  Microalgae is an 
excellent natural source of highly potent omega-3 fatty acids and other functional compounds 
that can benefit the brain health across the entire lifespan (Sathasivam et al., 2017; Wells et 
al., 2017). Because of its high content of functional compounds with high biological value, 
the World Health Organization (WHO) has regarded microalgae as a future human 
superfood, especially for the developing world. The present innovation takes advantage of 
Tanzania being one of the best countries with natural conditions that favor growth of this 
natural superfood (microalgae) in Eastern Africa region (Antonio, 2012). 
Apart from omega-3 fatty acids, single serving of the optimized formulation contains 15 mg 
and 95 mcg of iron and vitamin A, respectively, which are reported as one of the most 
limiting nutrients among children in the developing world. This amount can achieve about 
100% and 50% of recommended daily intake (RDI) for iron and vitamin A, respectively, for 
a 1 to 3-year-old child. This amount can also achieve about 60% RDI for iron and 
approximately 30% RDI for vitamin A, for an adolescent girl (FAO/WHO, 2004). Likewise, 
one serving of the optimized formulation can achieve 100% RDI for vitamin B3, 100% RDI 
for vitamin B6, 70% RDI for vitamin C, 60% RDI for vitamin E, 100% RDI for zinc and 
more than 100% RDI for magnesium for the child aged 12-36 months (FAO/WHO, 2004). 
All these nutrients are cofactors for the conversion of ALA into DHA in the human body. 
This means that the proposed optimized formulation is in a position to offer adequate amount 
of precursors which when absorbed can help consumers get more DHA from ALA 
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conversion in the body (Thome Research Inc., 2009). The formulation can also provide more 
than 100% RDI for lysine, threonine, methionine and tryptophan (limiting essential amino 
acids), respectively, for children aged between 1 and 2 years (FAO/WHO/UNU, 2007). In 
fact, the optimized formulation meets the recommended protein content of 10 to 12 percent of 
kcal and have a protein digestibility corrected amino acid score (PDCAAS) of 1.0 as per 
international standards (USDA, 2012). This makes the present formulation to have the protein 
with high biological value as that of meat and fish. The energy content (520 kcal) of the 
present formulation (Table 1) meets the international standards for ready to use therapeutic 
foods, which ranges between 520-550 kilocalories (kcal) per 100 g. The contribution of fatty 
acids to this energy is 0.3% for total omega-3 fatty acids and 3% for total omega-6 fatty 
acids, all of which are within the international specifications for ready-to-use foods (USDA, 
2012).  Likewise, the present formulation does not contain artificial antioxidants and artificial 
flavorings as per recommended standards for ready to use therapeutic foods. The present 
formulation is also free from table sugar, instead it contains dried fruits for sweet taste, 
making it a future candidate for the management of diabetic conditions among vulnerable 
individuals in low income countries like Tanzania. The texture of the present formulation is a 
fine paste that can be squeezed easily into the mouth by a child or by his/her caregiver as per 
international standards (USDA, 2012). Furthermore, peanut was not included (despite its 
availability) because of safety concerns associated with reported aflatoxin contamination in 
groundnuts (Duclercq, 2014). 
The LP analysis showed that it is possible to design a novel RUF formulae at a relatively low 
cost using locally available ingredients. The ingredient price of the proposed formulation is 
USD 0.15/100 g, which is lower than that of Plumpy’nut by approximately 50%. The lower 
price of the present formulation is due to relatively low cost of the selected ingredients. All 
ingredients in the present formulation can be sourced locally in Tanzania throughout the year 
with minimal transport and logistic costs. The opposite is true for the typical ready to use 
therapeutic foods, such as Plumpy'nut and Plumpy'doz. The cost of ingredients in these 
commonly used ready to use foods is high. Most commonly used ready-to-use foods are 
manufactured from vegetable oil, peanuts, milk powder, sugar and micronutrient supplements 
(Brixi, 2018). Peanuts and milk powder account for over 50% of product mass and for the 
total cost of ingredients (Brixi, 2018). The global supply chain, transport and logistics for 
most commonly used ready to use foods are costly. Ingredients for these foods are typically 
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shipped to the global manufacturing sites, mainly in France and the United States, and then 
transported to communities in need (Bazzano et al., 2017).  
The UNICEF analysis of the supply chain of Plumpy'nut to Africa shows that air 
transportation is often required, bringing transportation cost to 39% of the product landed 
cost (UNICEF, 2009). Intellectual property protection and licensing has raised the cost and 
constrained the global supply of typical ready to use therapeutic foods like Plumpy'nut 
(Bakhsh, 2012).  In fact, the high cost of commonly used ready to use therapeutic foods has 
been found as the primary reason for donors' inability to meet the basic nutrition needs in 
developing countries (UNICEF, 2009). Cost constraint of the typical ready to use foods 
prompted us to develop an alternative formulation, which takes advantage of the availability 
of ingredients and the possibility of localizing production close to communities in need. With 
the aid of linear programming (LP) tool, the study managed to design an alternative 
formulation with elevated content of preformed omega‐3 DHA and EPA, amino acids, 
minerals and essential cofactors for the ALA conversion, all of which are precursors to 
neurotransmitters. 
The downside of the LP analysis is that nutrient data were obtained from different sources 
that are likely to have some discrepancies in ingredients’ nutritional values. Some data were 
obtained from Tanzania Food Composition Tables, which currently does not contain all 
nutrient data for the identified ingredients. The missing nutrient composition for the 
candidate ingredients were imputed from other sources such as USDA nutrition database, 
Canadian Nutrient File, Danish Food Composition Database and peer reviewed papers. One 
should however, understand that nutrient composition of foods is known to vary within and 
across regions and countries (Merchant & Dehghan, 2006). This might have affected the 
present analysis, especially if the final nutrient composition of candidate foods was not 
accurate. Laboratory LP analysis of the nutrient values for the candidate ingredients will 
prevent mistakes resulting from discrepancies in ingredient nutritional value compared with 
current databases. Further laboratory testing of the prototype formulation could confirm 
accuracy of estimated essential nutrients and anti-nutrient composition.  
In order to address the aforementioned limitations of the LP analysis, a product prototype 
was developed. Thereafter, its nutritional values were established in the laboratory. The 
laboratory results were then compared with that of LP analysis. The laboratory analysis 
confirmed that the nutritional values of the prototype formulation were within the pre-
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established cutoffs established in the LP analysis (Table 2). In addition, acceptability testing 
was conducted to ascertain consumer perception regarding sensory qualities of the developed 
product. The results from sensory testing showed that almost all consumers liked sensory 
attributes of the product very much, confirming that the prototype formulation adequately 
met the sensory preferences of consumers. Similarly, the econometric analysis of this study 
showed that almost all primary caregivers were willing to pay at least 500 Tsh (US$ 0.15) for 
the prototype formulation, confirming a probable minimum retail price that was pre-
estimated in the LP tool. Econometric experiment further showed that caregivers’ education 
persists as a strong predictor of WTP for the prototype formulation. However, experiments in 
a large population could further validate the quality of prototype formulation and help us 
modify and improve the nutritional constraints of the product. Additionally, testing for true 
ileal protein digestibility for calculating Digestible Indispensable Amino Acid Score 
(DIAAS) would also validate the quality of the present optimized product. But all in all, the 
findings from the LP analysis and that of laboratory analysis showed that an alternative ready 
to use food with an elevated content of preformed DHA and EPA, as well as high quality 
protein can be formulated from local ingredients (other than costly dairy ingredients) for the 





CONCLUSION AND RECOMMENDATIONS 
5.1 Conclusion 
The findings from this study have showed that affordable ready-to-use food rich in 
bioavailable omega-3 DHA and EPA as well as other essential nutrients can be developed 
from locally available ingredients (other than costly dairy and fish oil ingredients) for the 
prevention and management of nutrition related mental health illnesses. The analysis of this 
study further showed that it is possible to develop a product that meets UN specifications set 
for ready-to-use foods for prevention of under nutrition using local ingredients that can be 
farmed in Tanzania and other parts of East Africa. Furthermore, the analysis from this study 
showed that microalgae, sesame seeds, pumpkin seeds, golden berries and baobab are 
primary ingredients that derived the composition of preformed omega-3 DHA and other 
essential nutrients with high biological value in the present optimal formulation. This study 
successfully developed a product rich in preformed omega-3 DHA and EPA as well as 
cofactors for the conversion of ALA in the body. This is the first study to develop a plant-
based food with elevated levels of preformed omega-3 DHA and EPA in Africa. It is also the 
first study to spark the need for developing omega-3 DHA dietary guideline, which is 
currently missing in Africa. 
The product contains about 220 mg of preformed omega-3 DHA+EPA, enough to meet the 
RDI for children aged 2-10 years. The product can also provide adequate amount of iron, 
zinc, vitamin A and high quality protein, which are generally regarded as limiting nutrients in 
developing countries. In addition, the formulated product is naturally packed with cofactors 
required for the conversion of omega-3 ALA into omega-3 DHA in the body. Moreover, the 
product contains a relatively well-balanced omega-6 to omega-3 fatty acids (2.5:1) ratio 
compared to commonly used RUFs in Africa. The nutritional composition of the product 
meets the UN standards for phytic acid to iron ratio, phytic acid to zinc ratio, calcium to 
phosphorus ratio and zinc to copper ratio, which are determinants of mineral absorption in 
the body. It also contains more than 95% PDCAAS, which is a measure of the protein 
quality. The product is free from added sugar; it contains natural sweet fruits with less 
carbohydrate, making it a future candidate for the prevention or management of diabetes. The 
product contains ingredients which international organizations are currently regarding them 
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as future innovative foods that will benefit human nutrition and the environment. Just as this 
study believes, international organizations also believe that these ingredients will replace 
meat as they have a relatively lower emission rate of greenhouse gases compared to meat.  
In the light of these findings, this product is worthy reaching as many people as possible in 
developing countries where prevalence of omega-3 deficiency is pervasive. In this case, a 
business-based approach could be the best tactic of ensuring a sustainable supply of the 
product in the community. As a means of executing this business idea, this study proposes a 
business model that encompasses smallholder farmers (mainly women group farmers), food 
processing centers and the public domain (government, non-governmental organizations 
(NGOs) and private companies) to ensure a sustainable supply of the present product to 
people who need it. In this business model, the study visualize that women group farmers 
will do the production of organic raw materials under the supervision of agricultural experts 
who will provide technical skills on organic farming and farming as business. The processing 
centers will engage themselves in processing, packaging and labeling of the product. The 
public domain, which may include the government and NGOs like UNICEF, WFP, WHO, 
GAIN, USAID and private companies will provide initial financial incentives and technical 
support for quick and sustainable distribution of the product to as many people as possible in 
Africa and other parts of the developing world. Based on the initial data on consumer 
acceptance and WTP experiments of this study, this product will be highly accepted in the 
community. 
Success of this business will have direct economic outcomes through contributing to mental 
health and wellbeing of consumers, value addition to the identified food ingredients, which 
may increase incomes and productivity at farm level. Through manufacturing and 
distribution processes, this business will create direct employments and increase the value of 
indirect jobs. Furthermore, products from this study will expand the choice space and at the 
same time supply bioavailable omega-3 DHA and other essential nutrients that are usually 
inadequate in most African diets. In so doing, the products will be addressing the diet related 
mental retardation, which is one of the major latent causes of economic stagnation in 
developing countries. The business idea of this product will create a “transpiration stream” to 
encourage farmers increase their acreage and productivity. It will also expand the local 
market for the produce of the identified food ingredients and thereby improve the price and 
turnover of the produce locally both of which will help secure farmer’s incomes. In fact, this 
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business idea will significantly contribute to global efforts of improving nutrition and health, 
and eventually eradicate poverty, which are one of the themes highlighted in the United 
Nations-Sustainable Development Goals (SDGs). 
5.2 Recommendations 
The limited sample size (n=60) may have made it difficult to identify other determinants with 
statistical significance on willingness to pay for the formulated product. There is a need for 
another WTP study with a relatively larger sample size to substantiate all potential 
determinants of consumer acceptance and willingness to pay for the formulated ready-to-use 
food in a population. Clinical and field efficacy trials in a large population are needed to 
validate the quality and performance of the formulated product in ensuring nutrition and 
mental health of the target population. Testing for true ileal protein digestibility for 
calculating digestible indispensable amino acid score (DIAAS) as commonly used in feed 
composition tables for pig is also needed to validate the quality of the formulated ready-to-
use food. 
Some studies have shown that utilization of omega-3 DHA by the brain may be affected by 
the permeability of the blood brain barrier (BBB) on its way to the brain tissues across the 
brain cells. In the capillaries that form the blood–brain barrier, endothelial cells are wedged 
extremely close to each other, forming the so-called tight junctions. The tight gap allows only 
small molecules, fat-soluble molecules and some gases to pass freely through the capillary 
wall and into brain tissue. In this aspect, nanotechnology to Nano-encapsulate omega-3 DHA 
is recommended to overcome the blood brain barriers that may affect proper utilization of 
this bioavailable essential fatty acid in the brain. The nanotechnology in this regard should 
involve the use of safer Nano-carriers that have been proven effective in carrying essential 
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